Cabozantinib Reverses Topotecan Resistance in Human Non-Small Cell Lung Cancer NCI-H460/TPT10 Cell Line and Tumor Xenograft Model

Overview of attention for article published in Frontiers in Cell and Developmental Biology, March 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 12 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 4,698 followers.

Cabozantinib Reverses Topotecan Resistance in Human Non-Small Cell Lung Cancer NCI-H460/TPT10 Cell Line and Tumor ... https://t.co/dIJWSX6UaD

11 Jul 2021

Reply Repost Favourite

New Research: Cabozantinib Reverses Topotecan Resistance in Human Non-Small Cell Lung Cancer NCI-H460/TPT10 Cell Line and Tumor Xenograft Model: Cabozantinib (CBZ) is a small molecule tyrosine kinase receptor inhibitor, which could also… https://t.co/ykgrF

22 Mar 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.